Pacira BioSciences (NASDAQ:PCRX) Upgraded by StockNews.com to “Strong-Buy”
StockNews.com upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday morning. Other equities research analysts have also issued reports about the company. Barclays lowered Pacira BioSciences from an overweight rating to an equal weight rating and dropped their price target for […]
More Stories
Trump Says Thailand, Cambodia Agree to Cease-Fire After Calls With Leaders
By Tom Ozimek President Donald Trump said on Dec. 12 that Thailand and Cambodia had agreed to halt fighting along...
ICE Arrests 2,824, Deports 11,870 in New Orleans in November
By Naveen Athrappully The Immigration and Customs Enforcement (ICE) New Orleans field office arrested 2,824 illegal immigrants in November and...
What to Know About Trump’s New ‘Gold Card’ Visa Program
By Savannah Hulsey Pointer Applications opened on Dec. 10 for the Trump administration’s new Gold Card program that expedites visas...
Watchdog Finds 9 Large US Banks Actively Engaged in Debanking
By Naveen Athrappully Nine of the largest banks have been found to engage in debanking activities, according to preliminary findings...
US Coast Guard Operation Seizes 150,000 Pounds of Cocaine
By Naveen Athrappully More than 150,000 pounds of cocaine have been seized in the Eastern Pacific Ocean since the launch...
Number of Americans Receiving Unemployment Benefits Falls to 10-Month Low
By Andrew Moran The number of Americans collecting unemployment benefits has slipped to its lowest point in 10 months, the...